Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Publications

Search Items: ANTINEOPLASTIC AGENTS - ADVERSE EFFECTS , . hits: 84

2022

Bergler-Klein, J; Rainer, PP; Wallner, M; Zaruba, MM; Dörler, J; Böhmer, A; Buchacher, T; Frey, M; Adlbrecht, C; Bartsch, R; Gyöngyösi, M; Fürst, UM Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Wien Klin Wochenschr. 2022; 134(17-18):654-674 Doi: 10.1007/s00508-022-02031-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moik, F; Ay, C Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
THROMB RES. 2022; 213: S58-S65. Doi: 10.1016/j.thromres.2022.01.004
Web of Science PubMed FullText FullText_MUG

 

2021

Moik, F; Makatsariya, A; Ay, C Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
Thromb Res. 2021; 199:38-42 Doi: 10.1016/j.thromres.2020.12.016
Web of Science PubMed FullText FullText_MUG

 

2019

Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I [Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366 Doi: 10.1007/s00105-019-4359-y (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Giuffrida, R; Kashofer, K; Dika, E; Patrizi, A; Baraldi, C; Di Meo, N; Zalaudek, I Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases.
Eur J Cancer. 2018; 91(2):177-179 Doi: 10.1016/j.ejca.2017.11.031 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kasteler, R; Kam, LMH; Weiss, A; Waespe, N; Sommer, G; Singer, F; von, der, Weid, NX; Ansari, M; Kuehni, CE, , Swiss, Pediatric, Oncology, Group, (SPOG) Monitoring pulmonary health in Swiss childhood cancer survivors.
Pediatr Blood Cancer. 2018; 65(10):e27255 Doi: 10.1002/pbc.27255
Web of Science PubMed FullText FullText_MUG

 

2017

Dulz, S; Asselborn, NH; Dieckmann, KP; Matthies, C; Wagner, W; Weidmann, J; Seidel, C; Oing, C; Berger, LA; Alsdorf, W; Mankichian, B; Meyer, C; Vetterlein, MW; Gild, P; Ludwig, TA; Soave, A; Schriefer, P; Becker, A; Ahyai, SA; Oechsle, K; Bokemeyer, C; Wagenfeld, L; Fisch, M; Hartmann, M; Chun, FK; Kluth, LA Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.
J Cancer Res Clin Oncol. 2017; 143(7):1319-1325 Doi: 10.1007/s00432-017-2384-8
Web of Science PubMed FullText FullText_MUG

 

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sarny, S; Neumayer, M; Kofler, J; El-Shabrawi, Y Ocular toxicity due to Trametinib and Dabrafenib.
BMC Ophthalmol. 2017; 17(1):146-146 Doi: 10.1186/s12886-017-0541-0 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71 Doi: 10.1111/bjh.14637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Koch, L; Lichem, R; Cerroni, L; Aberer, W; Massone, C Dermatitis, nonmelanoma skin cancer and leg ulcers.
CLIN EXP DERMATOL. 2016; 41(8): 943-944. Doi: 10.1111/ced.12896 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Lee, SB; Weide, B; Ugurel, S; Mössner, R; Enk, A; Hassel, JC Vemurafenib-induced granuloma annulare.
J Dtsch Dermatol Ges. 2016; 14(3):305-308 Doi: 10.1111/ddg.12777 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2015

Cerny-Reiterer, S; Rabenhorst, A; Stefanzl, G; Herndlhofer, S; Hoermann, G; Müllauer, L; Baumgartner, S; Beham-Schmid, C; Sperr, WR; Mannhalter, C; Sill, H; Linkesch, W; Arock, M; Hartmann, K; Valent, P Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Oncotarget. 2015; 6(5):3071-3084 Doi: 10.18632/oncotarget.3074 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Drummond, A; Pichler, J; Argenziano, G; Zalaudek, I; Longo, C; Lallas, A; Piana, S; Moscarella, E Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Australas J Dermatol. 2015; 56(4):e105-e107 Doi: 10.1111/ajd.12151 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Grassi, L; Berardi, MA; Ruffilli, F; Meggiolaro, E; Andritsch, E; Sirgo, A; Caruso, R; Juan Linares, E; Bellé, M; Massarenti, S; Nanni, MG; IOR-IRST Psycho-Oncology and UniFE Psychiatry Co-Authors Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Psychother Psychosom. 2015; 84(6):339-347 Doi: 10.1159/000431256 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 Doi: 10.1186/s12885-015-1373-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kremer, M; Manzini, G; Hristov, B; Polychronidis, G; Mokry, T; Sommer, CM; Mehrabi, A; Weitz, J; Büchler, MW; Schemmer, P Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
J Am Coll Surg. 2015; 221(3):717-728 Doi: 10.1016/j.jamcollsurg.2015.05.017
Web of Science PubMed FullText FullText_MUG

 

Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I [Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement].
Nuklearmedizin. 2015; 54(3):125-130 Doi: 10.3413/Nukmed-0688-14-07
Web of Science PubMed FullText FullText_MUG

 

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 Doi: 10.1056/NEJMoa1503093 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853 Doi: 10.1097/CAD.0000000000000108
Web of Science PubMed FullText FullText_MUG

 

Gary, T Cancer related venous thromboembolism - prophylaxis and therapy.
Vasa. 2014; 43(4):245-251 Doi: 10.1024/0301-1526/a000359
Web of Science PubMed FullText FullText_MUG

 

Lozanovski, VJ; Houben, P; Hinz, U; Hackert, T; Herr, I; Schemmer, P Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial.
Trials. 2014; 15(2):204-204 Doi: 10.1186/1745-6215-15-204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schrama, D; Groesser, L; Ugurel, S; Hafner, C; Pastrana, DV; Buck, CB; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.
JAMA Dermatol. 2014; 150(11):1180-1186 Doi: 10.1001/jamadermatol.2014.1116 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510 Doi: 10.1158/1078-0432.CCR-13-1411 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wutte, N; Palfner, M; Auer, H; Ruckenbauer, G; Valentin, T; Seeber, K; Aberer, W; Krause, R; Hoenigl, M Toxocarosis and putative DRESS syndrome in an oncological patient: a case report.
Wien Klin Wochenschr. 2014; 126 Suppl 1(2):S51-S55 Doi: 10.1007/s00508-013-0444-x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2013

Duvic, M; Dummer, R; Becker, JC; Poulalhon, N; Romero, PO; Bernengo, MG; Lebbe, C; Assaf, C; Squier, M; Williams, D; Marshood, M; Tai, F; Prince, HM; Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial.
EUR J CANCER. 2013; 49(2): 386-394. Doi: 10.1016/j.ejca.2012.08.017
Web of Science PubMed FullText FullText_MUG

 

Gisondi, P; Cazzaniga, S; Chimenti, S; Giannetti, A; Maccarone, M; Picardo, M; Girolomoni, G; Naldi, L; Psocare Study Group Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.
J Eur Acad Dermatol Venereol. 2013; 27(1):e30-e41 Doi: 10.1111/j.1468-3083.2012.04450.x
Web of Science PubMed FullText FullText_MUG

 

Müller, E; Seidel, MG; Lackner, H; Dworzak, M; Urban, C Acute promyelocytic leukemia complicated by massive intracerebral hemorrhage: safety and efficacy of replacing conventional chemotherapy with arsenic trioxide in an adolescent.
Klin Padiatr. 2013; 225(3):172-173 Doi: 10.1055/s-0033-1334898 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Yamanaka, K; Petrulionis, M; Lin, S; Gao, C; Galli, U; Richter, S; Winkler, S; Houben, P; Schultze, D; Hatano, E; Schemmer, P Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Cancer Med. 2013; 2(6):862-871 Doi: 10.1002/cam4.150 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Bjelic-Radisic, V; Jensen, PT; Vlasic, KK; Waldenstrom, AC; Singer, S; Chie, W; Nordin, A; Greimel, E Quality of life characteristics inpatients with cervical cancer.
Eur J Cancer. 2012; 48(16):3009-3018 Doi: 10.1016/j.ejca.2012.05.011
Web of Science PubMed FullText FullText_MUG

 

Flaherty, KT; Robert, C; Hersey, P; Nathan, P; Garbe, C; Milhem, M; Demidov, LV; Hassel, JC; Rutkowski, P; Mohr, P; Dummer, R; Trefzer, U; Larkin, JMG; Utikal, J; Dreno, B; Nyakas, M; Middleton, MR; Becker, JC; Casey, M; Sherman, LJ; Wu, FS; Ouellet, D; Martin, AM; Patel, K; Schadendorf, D; Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma.
N ENGL J MED. 2012; 367(2): 107-114. Doi: 10.1056/NEJMoa1203421 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous side effects of new antitumor drugs: clinical features and management.
Dtsch Arztebl Int. 2012; 109(8):133-140 Doi: 10.3238/arztebl.2012.0133 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pinter, M; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Stauber, R; Grünberger, B; Müller, C; Kölblinger, C; Peck-Radosavljevic, M; Sieghart, W Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Radiology. 2012; 263(2):590-599 Doi: 10.1148/radiol.12111550 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von, Lewinski, D; Pichler, M Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-62 Doi: 10.1111/j.1464-410X.2012.11134.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stupp, R; Wong, ET; Kanner, AA; Steinberg, D; Engelhard, H; Heidecke, V; Kirson, ED; Taillibert, S; Liebermann, F; Dbaly, V; Ram, Z; Villano, JL; Rainov, N; Weinberg, U; Schiff, D; Kunschner, L; Raizer, J; Honnorat, J; Sloan, A; Malkin, M; Landolfi, JC; Payer, F; Mehdorn, M; Weil, RJ; Pannullo, SC; Westphal, M; Smrcka, M; Chin, L; Kostron, H; Hofer, S; Bruce, J; Cosgrove, R; Paleologous, N; Palti, Y; Gutin, PH NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Eur J Cancer. 2012; 48(14):2192-2202 Doi: 10.1016/j.ejca.2012.04.011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Eschenhagen, T; Force, T; Ewer, MS; de Keulenaer, GW; Suter, TM; Anker, SD; Avkiran, M; de Azambuja, E; Balligand, JL; Brutsaert, DL; Condorelli, G; Hansen, A; Heymans, S; Hill, JA; Hirsch, E; Hilfiker-Kleiner, D; Janssens, S; de Jong, S; Neubauer, G; Pieske, B; Ponikowski, P; Pirmohamed, M; Rauchhaus, M; Sawyer, D; Sugden, PH; Wojta, J; Zannad, F; Shah, AM Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
EUR J HEART FAIL. 2011; 13(1): 1-10. Doi: 10.1093/eurjhf/hfq213 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Gutzmer, R; Becker, JC; Enk, A; Garbe, C; Hauschild, A; Leverkus, M; Reimer, G; Treudler, R; Tsianakas, A; Ulrich, C; Wollenberg, A; Homey, B Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.
J Dtsch Dermatol Ges. 2011; 9(3):195-202 Doi: 10.1111/j.1610-0387.2010.07561.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Henke, M; Alfonsi, M; Foa, P; Giralt, J; Bardet, E; Cerezo, L; Salzwimmer, M; Lizambri, R; Emmerson, L; Chen, MG; Berger, D Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
J CLIN ONCOL. 2011; 29(20): 2815-2820. Doi: 10.1200/JCO.2010.32.4103 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Le, QT; Kim, HE; Schneider, CJ; Murakozy, G; Skladowski, K; Reinisch, S; Chen, Y; Hickey, M; Mo, M; Chen, MG; Berger, D; Lizambri, R; Henke, M Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
J CLIN ONCOL. 2011; 29(20): 2808-2814. Doi: 10.1200/JCO.2010.32.4095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mikalauskas, S; Mikalauskiene, L; Bruns, H; Nickkholgh, A; Hoffmann, K; Longerich, T; Strupas, K; Büchler, MW; Schemmer, P Dietary glycine protects from chemotherapy-induced hepatotoxicity.
Amino Acids. 2011; 40(4):1139-1150 Doi: 10.1007/s00726-010-0737-6
Web of Science PubMed FullText FullText_MUG

 

Sill, H; Olipitz, W; Zebisch, A; Schulz, E; Wölfler, A Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Br J Pharmacol. 2011; 162(4): 792-805. Doi: 10.1111/j.1476-5381.2010.01100.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Hanzer, M; Nebl, A; Spendel, S; Pilhatsch, A; Urban, C; Benesch, M Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Klin Padiatr. 2010; 222(3): 184-186. Doi: 10.1055/s-0030-1249093
Web of Science PubMed FullText FullText_MUG

 

2009

Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R; Austrian Breast and Colorectal Cancer Study Group Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Clin Breast Cancer. 2009; 9 Suppl 1: S18-S27. Doi: 10.3816/CBC.2009.s.002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Haxhija, EQ; Lackner, H; Höllwarth, ME Medical treatment of children with hemangiomas and its limitations
Handchir Mikrochir Plast Chir. 2009; 41(2): 78-82. Doi: 10.1055/s-2008-1038772
Web of Science PubMed FullText FullText_MUG

 

Mlineritsch, B; Schabel-Moser, R; Andel, J; Fridrik, M; Moik, M; Mayer, P; Russ, G; Rass, C; Greil, R; Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Onkologie. 2009; 32(1-2):18-24 Doi: 10.1159/000180915
Web of Science PubMed FullText FullText_MUG

 

2008

Beer, M; Stenzel, M; Girschick, H; Schlegel, PG; Dargel, K Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: Preliminary results
Rofo. 2008; 180(3):238-245 Doi: 10.1055/s-2008-1027185
Web of Science PubMed FullText FullText_MUG

 

Hauschild, A; Trefzer, U; Garbe, C; Kaehler, KC; Ugurel, S; Kiecker, F; Eigentler, T; Krissel, H; Schott, A; Schadendorf, D Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma Res. 2008; 18(4):274-278 Doi: 10.1097/CMR.0b013e328307c248
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Petru, E; Andel, J; Angleitner-Boubenizek, L; Steger, G; Bernhart, M; Busch, K; Gehmacher, O; Hernler, T; Kastner, U; Lanz-Veit, A; Pluschnigg, U; Polachova, J; Rohde, M; Schiller, L; Schramböck, R; Stangl, W; Thödtmann, R; Zabernigg, A Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Wien Med Wochenschr. 2008; 158(5-6): 169-173. Doi: 10.1007/s10354-008-0515-1
PubMed FullText FullText_MUG Google Scholar

 

Pföhler, C; Ugurel, S Cutaneous reactions to molecular targeted therapies.
Hautarzt. 2008; 59(10):814-820 Doi: 10.1007/s00105-008-1540-0
Web of Science PubMed FullText FullText_MUG

 

Ulrich, J; Hartmann, JT; Dörr, W; Ugurel, S Skin toxicity of anti-cancer therapy.
J Dtsch Dermatol Ges. 2008; 6(11):959-977 Doi: 10.1111/j.1610-0387.2008.06831.x
Web of Science PubMed FullText FullText_MUG

 

Show the next 50 results of search

↑ Top of page / Navigation

© Med Uni Graz • Imprint